Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,552 across all filing types
Latest filing 2025-01-22 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a disclosure submitted under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It reports an order issued by the Office of the Joint Commissioner of Income Tax regarding a Transfer Pricing order for AY 2022-23 with a claim amount. The document is a regulatory announcement about a tax authority order and its impact on the company, not a full financial report, audit report, or earnings release. It is a compliance disclosure under listing regulations, which fits best under Regulatory Filings (RNS). The document length is short (3209 characters) and it is an announcement rather than a detailed report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-01-22 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It details a demand notice issued by a government authority regarding an excess sanction of MEIS duty credit and accrued interest. The document is a formal notification to stock exchanges about a regulatory or compliance matter affecting the company. It does not contain financial statements, audit results, or detailed financial performance data. It is not a report but an announcement of a regulatory event or compliance disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-01-08 English
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It details a demand notice issued by a government authority regarding a financial matter (excess sanction of MEIS duty credit and interest). The document is a formal announcement to stock exchanges about a regulatory or compliance-related event affecting the company. It does not contain financial statements, audit results, or detailed financial performance data. It is not a report itself but a regulatory announcement about a specific event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-01-08 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, stating that the promoter and persons acting in concert have not made any encumbrance on the equity shares held. This is a notification related to shareholding and encumbrance status, which fits the category of Major Shareholding Notification (MRQ). The document is short and does not contain financial statements or detailed financial data, so it is not an annual or interim report. It is not a voting result, management change, or other categories. Therefore, the best fit is MRQ.
2025-01-07 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-01-07 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, provided by the Registrar and Share Transfer Agent (RTA) for the period ended 31st December 2024. It is a confirmation certificate related to dematerialisation of securities and compliance with SEBI regulations. The document is short (3263 characters) and primarily serves as a certification or attestation rather than a full financial report or detailed filing. It does not contain financial statements or substantive financial data. Therefore, it fits the criteria for a Regulatory Filing (RNS) as it is a regulatory compliance certificate and not a full report or announcement of a report.
2025-01-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.